Apixaban-[d3]
Isotopic labelled form of Apixaban. Apixaban (INN, trade name Eliquis) is an anticoagulant for the prevention of venous thromboembolism and the prevention of stroke in atrial fibrillation. It is a direct factor Xa inhibitor. Apixaban has been available in Europe since May 2011. The drug was developed in a joint venture by Pfizer and Bristol-Myers Squibb.
| Supplier | BOC Sciences |
|---|---|
| Product # | BLP-003323 |
| Pricing | Inquire |
| Cas | 1131996-12-7 |
| Molecular Weight | 462.52 |
| Molecular Formula | C25H22D3N5O4 |
| Canonical SMILES | COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N |